HYBRIGENICS S.A.
10Patents
8Active
10Granted
46Portfolio score
Filing activity: Oct 30, 2001 → Jul 20, 2017 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9546150B2 | Substituted quinazolin-4-ones for inhibiting ubiquitin specific protease 7 | Chemistry; Metallurgy | 26 | Active |
| US7462615B2 | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications | Chemistry; Metallurgy | 4 | Expired |
| US8481514B2 | Therapeutical uses of inecalcitol | Human Necessities | 2 | Active |
| US7875613B2 | Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications | Human Necessities | 1 | Active |
| US6916615B2 | Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof | Chemistry; Metallurgy | 1 | Expired |
| US8648076B2 | Cysteine protease inhibitors and their therapeutic applications | Human Necessities | 1 | Active |
| US10478497B2 | Combinations of inecalcitol with an anti-CD38 agent and their uses for treating cancer | Human Necessities | 0 | Active |
| US9314474B2 | Formulations of 14-epi-analogues of vitamin D | Human Necessities | 0 | Active |
| US9315455B2 | Process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the same | Chemistry; Metallurgy | 0 | Active |
| US9328093B2 | Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.